These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8131019)
1. Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological Group. Kiemeney LA; Witjes JA; Heijbroek RP; Koper NP; Verbeek AL; Debruyne FM Br J Urol; 1994 Feb; 73(2):164-71. PubMed ID: 8131019 [TBL] [Abstract][Full Text] [Related]
2. Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer. Kiemeney LA; Witjes JA; Heijbroek RP; Debruyne FM; Verbeek AL Eur J Cancer; 1994; 30A(11):1621-5. PubMed ID: 7833133 [TBL] [Abstract][Full Text] [Related]
3. [Significance of random biopsies of healthy mucosa in superficial bladder tumor]. Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385 [TBL] [Abstract][Full Text] [Related]
5. Clinical impact of bladder biopsies with TUR-BT according to cytology results in patients with bladder cancer: a case control study. Matsushima M; Kikuchi E; Hasegawa M; Matsumoto K; Miyajima A; Oya M BMC Urol; 2010 Jun; 10():12. PubMed ID: 20591189 [TBL] [Abstract][Full Text] [Related]
15. The significance of bladder quadrant biopsies in patients with primary superficial bladder carcinoma. Flamm J; Dona S Eur Urol; 1989; 16(2):81-5. PubMed ID: 2714336 [TBL] [Abstract][Full Text] [Related]
16. Comparison of expected treatment outcomes, obtained using risk models and international guidelines, with observed treatment outcomes in a Dutch cohort of patients with non-muscle-invasive bladder cancer treated with intravesical chemotherapy. Lammers RJ; Palou J; Witjes WP; Janzing-Pastors MH; Caris CT; Witjes JA BJU Int; 2014 Aug; 114(2):193-201. PubMed ID: 24304638 [TBL] [Abstract][Full Text] [Related]
17. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. Kiemeney LA; Witjes JA; Heijbroek RP; Verbeek AL; Debruyne FM J Urol; 1993 Jul; 150(1):60-4. PubMed ID: 8510276 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection. Chang WC; Chang YH; Pan CC Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706 [TBL] [Abstract][Full Text] [Related]
19. Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub Group. Richards B; Parmar MK; Anderson CK; Ansell ID; Grigor K; Hall RR; Morley AR; Mostofi FK; Risdon RA; Uscinska BM Br J Urol; 1991 Apr; 67(4):369-75. PubMed ID: 2032076 [TBL] [Abstract][Full Text] [Related]
20. [pT1G3 bladder carcinoma: parameters of a correct therapy]. Ruoppolo M; Dell'Orto P; Fenice O; Seveso M; Ferri P; Zaatar C; Tagliaferri A; Cogni M; Bellorofonte G; Tombolini P Arch Ital Urol Androl; 1996 Feb; 68(1):17-20. PubMed ID: 8664914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]